is semaglutide under patent Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Magic pill' moment? What happens

Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.

It's possible to maintain weight loss after bariatric surgery or stopping GLP-1 drugs

Explore Mochi Health, covering how the program prescribes the compound, pricing, and the PlexusDx alternative

Available in Two Sizes: 1-Pack (30 patches): Compact and convenient for customers seeking a simple daily solution, priced at $8.99

GLP-1s, and mor medications, nutrition, exercise, genetic testing & body composition analysis.

Theyre treating real diseases that affect millions of people, but theyre not the growth story anymore